Page last updated: 2024-11-02

piracetam and Osteoporosis

piracetam has been researched along with Osteoporosis in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research Excerpts

ExcerptRelevanceReference
"Levetiracetam (LEV) is an anti-seizure drug (ASD)."5.72Relationship between bone density and levetiracetam monotherapy in epilepsy patients. ( Aydın, Z; Gözükızıl, ST; Yalçın, AD, 2022)
"Levetiracetam (LEV) is an anti-seizure drug (ASD)."1.72Relationship between bone density and levetiracetam monotherapy in epilepsy patients. ( Aydın, Z; Gözükızıl, ST; Yalçın, AD, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gözükızıl, ST1
Aydın, Z1
Yalçın, AD1
Artemiadis, AK1
Lambrinoudaki, I1
Voskou, P1
Tsivgoulis, G1
Safouris, A1
Bougea, A1
Giannopoulos, S1
Gatzonis, S1
Triantafyllou, N1

Other Studies

2 other studies available for piracetam and Osteoporosis

ArticleYear
Relationship between bone density and levetiracetam monotherapy in epilepsy patients.
    Clinical neurology and neurosurgery, 2022, Volume: 218

    Topics: Adolescent; Adult; Anticonvulsants; Bone Density; Cross-Sectional Studies; Epilepsy; Female; Humans;

2022
Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy.
    Epilepsy & behavior : E&B, 2016, Volume: 55

    Topics: Adult; Anticonvulsants; Bone Density; Cohort Studies; Drug Administration Schedule; Epilepsy; Female

2016